FOXO Technologies majority stockholder approves authorized share increase from 10B to 25B

FOXO TECHNOLOGIES INC.

Majority stockholder (Rennova Health, Inc., controlled by CEO) holding 97.59% voting rights approved via written consent on March 27, 2026.
Amendment increases authorized Class A Common Stock from 10,000,000,000 to 25,000,000,000 shares.
Effective date will be 20 days after mailing of definitive Information Statement; preliminary 14C filed April 1, 2026.
Board has discretion to set effective date without further stockholder approval.
Record date for consent was March 20, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.